Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus

NCT03442751 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.

NCT NCT03442751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03442751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multi-center Study to Evaluate the Safety and Efficacy of Epithelium-on Corneal Collagen Cross-linking in Eyes With Progressive Keratoconus
Lead sponsor
Glaukos Corporation
Phase
Phase 3
Overall status
Completed
Start date
April 6, 2018
Completion date
August 10, 2020
Enrollment
201 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

progressive keratoconus